抓住罪魁祸首：将靶向抗 miR 核酸递送至肝癌细胞中隔离致癌性 miR-221 - Suppr

Arresting the Culprit: Targeted Antagomir Delivery to Sequester Oncogenic miR-221 in HCC.

作者信息

Kasinski Andrea L, Slack Frank J

机构信息

Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, Connecticut, USA.

出版信息

Mol Ther Nucleic Acids. 2012 Mar 20;1(3):e12. doi: 10.1038/mtna.2012.2.

DOI:10.1038/mtna.2012.2

PMID:23343881

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3381591/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf81/3381591/ab7207b7f98e/mtna20122f1.jpg

相似文献

Arresting the Culprit: Targeted Antagomir Delivery to Sequester Oncogenic miR-221 in HCC.

Mol Ther Nucleic Acids. 2012 Mar 20;1(3):e12. doi: 10.1038/mtna.2012.2.

Targeted Delivery of miRNA Antagonists to Myeloid Cells In Vitro and In Vivo.

Methods Mol Biol. 2019;1974:141-150. doi: 10.1007/978-1-4939-9220-1_10.

Intranasal Delivery of miR-155-5p Antagomir Alleviates Acute Seizures Likely by Inhibiting Hippocampal Inflammation.

Neuropsychiatr Dis Treat. 2020 May 20;16:1295-1307. doi: 10.2147/NDT.S247677. eCollection 2020.

Targeted delivery of miR-218 via decorated hyperbranched polyamidoamine for liver cancer regression.

Int J Pharm. 2021 Dec 15;610:121256. doi: 10.1016/j.ijpharm.2021.121256. Epub 2021 Oct 31.

The E3 ligase for metastasis associated 1 protein, TRIM25, is targeted by microRNA-873 in hepatocellular carcinoma.

Exp Cell Res. 2018 Jul 1;368(1):37-41. doi: 10.1016/j.yexcr.2018.04.010. Epub 2018 Apr 12.

Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation.

J Ethnopharmacol. 2019 Mar 1;231:98-112. doi: 10.1016/j.jep.2018.11.007. Epub 2018 Nov 6.

Inhibiting the oncogenic mir-221 by microRNA sponge: toward microRNA-based therapeutics for hepatocellular carcinoma.

Gastroenterol Hepatol Bed Bench. 2014 Winter;7(1):43-54.

Inhibition of miR-155 in MCF-7 breast cancer cell line by gold nanoparticles functionalized with antagomir and AS1411 aptamer.

J Cell Physiol. 2020 Oct;235(10):6887-6895. doi: 10.1002/jcp.29584. Epub 2020 Jan 31.

Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells.

Mol Cancer. 2011 May 19;10:59. doi: 10.1186/1476-4598-10-59.

AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension.

Eur Heart J. 2014 Dec 1;35(45):3203-11. doi: 10.1093/eurheartj/ehs060. Epub 2012 Mar 26.

引用本文的文献

Recent trends in miRNA therapeutics and the application of plant miRNA for prevention and treatment of human diseases.

Futur J Pharm Sci. 2022;8(1):24. doi: 10.1186/s43094-022-00413-9. Epub 2022 Apr 1.

Long non-coding RNA SNHG1 promotes cell proliferation and invasion of hepatocellular carcinoma by acting as a molecular sponge to modulate miR-195.

Arch Med Sci. 2019 Jan 16;16(2):386-394. doi: 10.5114/aoms.2019.81311. eCollection 2020.

Kruppel-like factor 4 signals through microRNA-206 to promote tumor initiation and cell survival.

Oncogenesis. 2015 Jun 8;4(6):e155. doi: 10.1038/oncsis.2015.8.

miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents.

Future Med Chem. 2014;6(17):1967-84. doi: 10.4155/fmc.14.116.

Non-coding RNAs as therapeutic targets in hepatocellular cancer.

Curr Cancer Drug Targets. 2012 Nov 1;12(9):1073-80.

本文引用的文献

Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy.

Nat Rev Cancer. 2011 Nov 24;11(12):849-64. doi: 10.1038/nrc3166.

The role of microRNAs in human liver cancers.

Semin Oncol. 2011 Dec;38(6):752-63. doi: 10.1053/j.seminoncol.2011.08.001.

miR-221 silencing blocks hepatocellular carcinoma and promotes survival.

Cancer Res. 2011 Dec 15;71(24):7608-16. doi: 10.1158/0008-5472.CAN-11-1144. Epub 2011 Oct 18.

Hepatocellular carcinoma.

N Engl J Med. 2011 Sep 22;365(12):1118-27. doi: 10.1056/NEJMra1001683.

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma.

Nature. 2010 Sep 2;467(7311):86-90. doi: 10.1038/nature09284. Epub 2010 Aug 8.

miR-221 overexpression contributes to liver tumorigenesis.

Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):264-9. doi: 10.1073/pnas.0907904107. Epub 2009 Dec 15.

RETRACTED: miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.

Cancer Cell. 2009 Dec 8;16(6):498-509. doi: 10.1016/j.ccr.2009.10.014.

Sorafenib in advanced hepatocellular carcinoma.

N Engl J Med. 2008 Jul 24;359(4):378-90. doi: 10.1056/NEJMoa0708857.

MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.

Oncogene. 2008 Sep 25;27(43):5651-61. doi: 10.1038/onc.2008.178. Epub 2008 Jun 2.

Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation.

EMBO J. 2007 Aug 8;26(15):3699-708. doi: 10.1038/sj.emboj.7601790. Epub 2007 Jul 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Arresting the Culprit: Targeted Antagomir Delivery to Sequester Oncogenic miR-221 in HCC.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献